Basophilia Predicts Poorer Outcomes in Essential Thrombocythemia, Polycythemia Vera, Primary Myelofibrosis, and Myeloproliferative Neoplasm, Unclassifiable

被引：0
|
作者：
Yuen, Lisa [1 ,2 ]
Gogakos, Tasos [1 ,2 ,3 ]
Boiocchi, Leonardo [4 ]
Hobbs, Gabriela [2 ,5 ]
Hasserjian, Robert [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
[4] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY USA
[5] Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2024年
关键词：
D O I：
10.1002/ajh.27530
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
    Hasserjian, Robert P.
    CURRENT CANCER THERAPY REVIEWS, 2012, 8 (01) : 14 - 29
  • [2] CALR, JAK2, and MPL Mutation Profiles in Patients With Four Different Subtypes of Myeloproliferative Neoplasms Primary Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera, and Myeloproliferative Neoplasm, Unclassifiable
    Kim, Seon Young
    Im, Kyongok
    Park, Si Nae
    Kwon, Jiseok
    Kim, Jung-Ah
    Lee, Dong Soon
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (05) : 635 - 644
  • [3] Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
    Agarwal, M. B.
    Malhotra, Hemant
    Chakrabarti, Prantar
    Varma, Neelam
    Mathews, Vikram
    Bhattacharyya, Jina
    Seth, Tulika
    Gayathri, K.
    Menon, Hari
    Subramanian, P. G.
    Sharma, Ajay
    Bhattacharyya, Maitreyee
    Mehta, Jay
    Vaid, A. K.
    Shah, Sandeep
    Aggarwal, Shyam
    Gogoi, P. K.
    Nair, Reena
    Agarwal, Usha
    Varma, Subhash
    Prasad, S. V. S. S.
    Manipadam, Marie Therese
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2015, 36 (01) : 3 - 16
  • [4] Interferon and the treatment of polycythemia vera, essential thrombocythemia and myelofibrosis
    Silver, Richard T.
    Kiladjian, Jean-Jacques
    Hasselbalch, Hans Carl
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (01) : 49 - 58
  • [5] Epidemiology of the myeloproliferative disorders polycythemia vera and essential thrombocythemia
    Johansson, P
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (03): : 171 - 173
  • [6] MicroRNA Expression Analysis in Patients with Primary Myelofibrosis, Polycythemia vera and Essential Thrombocythemia
    Anil Tombak
    Ozlem Izci Ay
    Mehmet Emin Erdal
    Mehmet Ali Sungur
    Mehmet Ali Ucar
    Aydan Akdeniz
    Eyup Naci Tiftik
    Indian Journal of Hematology and Blood Transfusion, 2015, 31 : 416 - 425
  • [7] MicroRNA Expression Analysis in Patients with Primary Myelofibrosis, Polycythemia vera and Essential Thrombocythemia
    Tombak, Anil
    Ay, Ozlem Izci
    Erdal, Mehmet Emin
    Sungur, Mehmet Ali
    Ucar, Mehmet Ali
    Akdeniz, Aydan
    Tiftik, Eyup Naci
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2015, 31 (04) : 416 - 425
  • [8] CLINICAL RECOMMENDATIONS FOR DIAGNOSIS AND THERAPY OF Rh-NEGATIVE MYELOPROLIFERATIVE DISEASES (POLYCYTHEMIA VERA, ESSENTIAL THROMBOCYTHEMIA, PRIMARY MYELOFIBROSIS)
    Melikyan, A. L.
    Turkina, A. G.
    Abdulkadyrov, K. M.
    Zaritsky, A. Yu
    Afanasyev, B., V
    Shuvaev, V. A.
    Lomaia, E. G.
    Morozova, E., V
    Baikov, V. V.
    Golenkov, A. K.
    Subortseva, I. N.
    Sokolova, M. A.
    Kovrigina, A. M.
    Martynkevich, I. S.
    Gritsaev, S., V
    Sudarikov, A. B.
    Sukhanova, G. A.
    Ivanova, V. L.
    Kaplanov, K. D.
    Konstantinova, T. S.
    Pospelova, T., I
    Ageeva, T. A.
    Shatokhin, Yu., V
    Saychenko, V. G.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2014, 59 (04): : 31 - 56
  • [9] Revised Myeloproliferative Neoplasms Working Group Consensus Recommendations for Diagnosis and Management of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocythemia
    Agarwal, Mohan B.
    Malhotra, Hemant
    Chakarborti, Prantar
    Varma, Neelam
    Mathews, Vikram
    Bhattacharyya, Jina
    Seth, Tulika
    Gyathri, K.
    Menon, Hari
    Subramanian, P. G.
    Sharma, Ajay K.
    Bhattacharyya, Maitreyee
    Mehta, Jay
    Shah, Sandeep
    Gogoi, P. K.
    Nair, Reena
    Agarwal, Usha
    Varma, Subhash
    Prasad, S. V. V. S.
    Mishra, Deepak K.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2018, 39 (04) : 503 - 515
  • [10] Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis
    Michiels, JJ
    Kutti, J
    Stark, P
    Bazzan, M
    Gugliotta, L
    Marchioli, R
    Griesshammer, M
    van Genderen, PJJ
    Brière, J
    Kiladjian, JJ
    Barbui, T
    Finazzi, G
    Berlin, NI
    Pearson, TC
    Green, AC
    Fruchtmann, SM
    Silver, RT
    Hansmann, E
    Wehmeier, A
    Lengfelder, E
    Landolfi, R
    Kvasnicka, HM
    Hasselbalch, H
    Cervantes, F
    Reilly, JT
    Demory, JL
    Gisslinger, H
    Guardiola, P
    Martyré, MC
    Le Bousse-Kerdilès, MC
    Thiele, J
    NETHERLANDS JOURNAL OF MEDICINE, 1999, 54 (02): : 46 - 62
12345